108 related articles for article (PubMed ID: 12538498)
1. Second International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: summary consensus statement.
Come SE; Buzdar AU; Arteaga CL; Brodie AM; Davidson NE; Dowsett M; Ingle JN; Johnston SR; Lee AV; Osborne CK; Pritchard KI; Vogel VG; Winer EP; Hart CS
Clin Cancer Res; 2003 Jan; 9(1 Pt 2):443S-6S. PubMed ID: 12538498
[No Abstract] [Full Text] [Related]
2. Proceedings of the First International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: summary consensus statement.
Buzdar AU; Come SE; Brodie A; Ellis M; Goss PE; Ingle JN; Johnston SR; Lee AV; Osborne CK; Vogel VG; Hart CS
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4335s-4337s; discussion 4411s-4412s. PubMed ID: 11916221
[No Abstract] [Full Text] [Related]
3. Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer?
Bedard PL; Freedman OC; Howell A; Clemons M
Breast Cancer Res Treat; 2008 Apr; 108(3):307-17. PubMed ID: 18351454
[TBL] [Abstract][Full Text] [Related]
4. Proceedings of the Fifth International Conference on Recent Advances and Future Directions in Endocrine Therapy for Breast Cancer: conference summary statement.
Come SE; Buzdar AU; Ingle JN; Arteaga CL; Brown M; Dowsett M; Hilsenbeck SG; Kumar R; Johnston SR; Lee AV; Paik S; Pritchard KI; Winer EP; Hart C
Clin Cancer Res; 2006 Feb; 12(3 Pt 2):997s-1000s. PubMed ID: 16467115
[No Abstract] [Full Text] [Related]
5. Proceedings of the Third International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer: conference summary statement.
Come SE; Buzdar AU; Arteaga CL; Bissell MJ; Brown MA; Ellis MJ; Goss PE; Green JE; Ingle JN; Lee AV; Medina D; Nicholson RI; Santen RJ; Schiff R; Hart CS
Clin Cancer Res; 2004 Jan; 10(1 Pt 2):327S-330S. PubMed ID: 14734487
[No Abstract] [Full Text] [Related]
6. Recent topics in endocrine therapy for hormone-dependent breast cancer: basic research and clinical applications.
Kimijima I
Breast Cancer; 2008; 15(4):253-5. PubMed ID: 18953680
[No Abstract] [Full Text] [Related]
7. Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer. Proceedings of the 5th International Conference, Cambridge, Massachusetts, USA, June 13-14, 2005.
Clin Cancer Res; 2006 Feb; 12(3 Pt 2):997s-1068s. PubMed ID: 16541524
[No Abstract] [Full Text] [Related]
8. Proceedings of the 2nd International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer. Cambridge, Massachusetts, USA, June 28-29, 2002.
Clin Cancer Res; 2003 Jan; 9(1 Pt 2):443S-532S; quiz i-vi. PubMed ID: 12838958
[No Abstract] [Full Text] [Related]
9. Novel mechanisms of resistance to endocrine therapy: genomic and nongenomic considerations.
Gururaj AE; Rayala SK; Vadlamudi RK; Kumar R
Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1001s-1007s. PubMed ID: 16467116
[TBL] [Abstract][Full Text] [Related]
10. Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancer.
Bodmer A; Castiglione-Gertsch M
Eur J Cancer; 2011 Sep; 47 Suppl 3():S28-37. PubMed ID: 21943985
[No Abstract] [Full Text] [Related]
11. Addressing the future: combination with targeted therapies, adjuvant setting and beyond.
Goss PE
Anticancer Drugs; 2008 Mar; 19 Suppl 2():S3-5. PubMed ID: 18337641
[TBL] [Abstract][Full Text] [Related]
12. The NFkappaB pathway and endocrine-resistant breast cancer.
Zhou Y; Eppenberger-Castori S; Eppenberger U; Benz CC
Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S37-46. PubMed ID: 16113098
[TBL] [Abstract][Full Text] [Related]
13. Prospects of neoadjuvant aromatase inhibitor therapy in breast cancer.
Dixon JM
Expert Rev Anticancer Ther; 2008 Mar; 8(3):453-63. PubMed ID: 18366292
[TBL] [Abstract][Full Text] [Related]
14. Is overcoming hormone resistance in breast cancer possible?
Orphanos G; Kakoullou N; Ardavanis A
J BUON; 2008; 13(3):315-22. PubMed ID: 18979544
[TBL] [Abstract][Full Text] [Related]
15. Proceedings of the 3rd International Conference on Recent Advances and Future Directions in Endocrine Manipulation of Breast Cancer.
Clin Cancer Res; 2004 Jan; 10(1 Pt 2):327S-409S; quiz i-iv. PubMed ID: 14981797
[No Abstract] [Full Text] [Related]
16. Advances in adjuvant endocrine therapy for postmenopausal women.
Lin NU; Winer EP
J Clin Oncol; 2008 Feb; 26(5):798-805. PubMed ID: 18258989
[TBL] [Abstract][Full Text] [Related]
17. Aromatase inhibitors and breast cancer.
Miller WR
Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
[TBL] [Abstract][Full Text] [Related]
18. Selecting endocrine therapy for breast cancer: what role does HER-2/neu status play?
Prowell TM; Armstrong DK
Semin Oncol; 2006 Dec; 33(6):681-7. PubMed ID: 17145348
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant hormonal therapy for premenopausal women with breast cancer.
Brown RJ; Davidson NE
Semin Oncol; 2006 Dec; 33(6):657-63. PubMed ID: 17145345
[TBL] [Abstract][Full Text] [Related]
20. The association between Akt activation and resistance to hormone therapy in metastatic breast cancer.
Tokunaga E; Kataoka A; Kimura Y; Oki E; Mashino K; Nishida K; Koga T; Morita M; Kakeji Y; Baba H; Ohno S; Maehara Y
Eur J Cancer; 2006 Mar; 42(5):629-35. PubMed ID: 16464571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
